313
Views
8
CrossRef citations to date
0
Altmetric
Review

Minimally invasive palliative interventions in advanced lung cancer

, , , , , & show all
Pages 605-614 | Received 16 Feb 2018, Accepted 06 Jun 2018, Published online: 19 Jun 2018

References

  • American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018.
  • Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–594.
  • SEER cancer stat facts: lung and bronchus cancer. National Cancer Institute, Bethesda, MD. [cited 2018 Feb 15]. Available from: http://seer.cancer.gov/statfacts/html/lungb.html
  • Pronzato P, Bertelli G, Losardo P, et al. What do advanced cancer patients know of their disease? A report from Italy. Support Care Cancer. 1994;2(4):242–244.
  • Eidinger RN, Schapira DV. Cancer patients’ insight into their treatment, prognosis, and unconventional therapies. Cancer. 1984;53(12):2736–2740.
  • Weeks JC, Cook EF, O’Day SJ, et al. Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA. 1998;279(21):1709–1714.
  • Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26(23):3860–3866.
  • Kadakia KC, Moynihan TJ, Smith TJ, et al. Palliative communications: addressing chemotherapy in patients with advanced cancer. Ann Oncol. 2012;23(Suppl 3):29–32.
  • Ernst A, Feller-Kopman D, Becker HD, et al. Central airway obstruction. Am J Respir Crit Care Med. 2004;169(12):1278–1297.
  • American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(5):1987–2001.
  • Dunger C, Higginson IJ, Gysels M, et al. Breathlessness and crises in the context of advanced illness: A comparison between COPD and lung cancer patients. Palliat Support Care. 2015;13(2):229–237.
  • Yarmus L, Ernst A, Feller-Kopman D. Emerging technologies for the thorax: indications, management and complications. Respirology. 2010;15(2):208–219.
  • Group BTSPDG, Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii32–40. •• Recommendations by the British Thoracic Society and the treatment of pleural disease. An important clinical guideline.
  • Simoff MJ, Lally B, Slade MG, et al. Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5Suppl):e455S–497S.
  • Beamis JF Jr. Interventional pulmonology techniques for treating malignant large airway obstruction: an update. Curr Opin Pulm Med. 2005;11(4):292–295.
  • Kamal AH, Maguire JM, Wheeler JL, et al. Dyspnea review for the palliative care professional: treatment goals and therapeutic options. J Palliat Med. 2012;15(1):106–114.
  • Curtis JL, Mahlmeister M, Fink JB, et al. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest. 1986;90(3):455–457.
  • Morrison RS, Maroney-Galin C, Kralovec PD, et al. The growth of palliative care programs in United States hospitals. J Palliat Med. 2005;8(6):1127–1134.
  • Barach AL. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med. 1935;9(6):739–765.
  • Pathak V, Welsby I, Mahmood K, et al. Ventilation and anesthetic approaches for rigid bronchoscopy. Ann Am Thorac Soc. 2014;11(4):628–634.
  • McDougall JC, Cortese DA. Neodymium-YAG laser therapy of malignant airway obstruction. A preliminary report. Mayo Clin Proc. 1983;58(1):35–39.
  • Van Der Spek AF, Spargo PM, Norton ML. The physics of lasers and implications for their use during airway surgery. Br J Anaesth. 1988;60(6):709–729.
  • Cavaliere S, Foccoli P, Farina PL. Nd:YAG laser bronchoscopy. A five-year experience with 1,396 applications in 1,000 patients. Chest. 1988;94(1):15–21.
  • Dumon JF, Shapshay S, Bourcereau J, et al. Principles for safety in application of neodymium-YAG laser in bronchology. Chest. 1984;86(2):163–168.
  • Hetzel MR, Nixon C, Edmondstone WM, et al. Laser therapy in 100 tracheobronchial tumours. Thorax. 1985;40(5):341–345.
  • Brutinel WM, Cortese DA, McDougall JC, et al. A two-year experience with the neodymium-YAG laser in endobronchial obstruction. Chest. 1987;91(2):159–165.
  • Cavaliere S, Venuta F, Foccoli P, et al. Endoscopic treatment of malignant airway obstructions in 2,008 patients. Chest. 1996;110(6):1536–1542.
  • Coulter TD, Mehta AC. The heat is on: impact of endobronchial electrosurgery on the need for Nd-YAG laser photoresection. Chest. 2000;118(2):516–521.
  • Wahidi MM, Unroe MA, Adlakha N, et al. The use of electrocautery as the primary ablation modality for malignant and benign airway obstruction. J Thorac Oncol. 2011;6(9):1516–1520.
  • Grund KE, Storek D, Farin G. Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy. Endosc Surg Allied Technol. 1994;2(1):42–46.
  • Kizilgoz D, Aktas Z, Yilmaz A, et al. Comparison of two new techniques for the management of malignant central airway obstruction: argon plasma coagulation with mechanical tumor resection versus cryorecanalization. Surg Endosc. 2017;32(4):1879–1884.
  • Morice RC, Ece T, Ece F, et al. Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest. 2001;119(3):781–787.
  • Moghissi K, Dixon K. Update on the current indications, practice and results of photodynamic therapy (PDT) in early central lung cancer (ECLC). Photodiagnosis Photodyn Ther. 2008;5(1):10–18.
  • Moghissi K, Dixon K, Stringer M, et al. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg. 1999;15(1):1–6.
  • Noppen M, Meysman M, Van Herreweghe R, et al. Bronchoscopic cryotherapy: preliminary experience. Acta Clin Belg. 2001;56(2):73–77.
  • Maiwand MO, Homasson JP. Cryotherapy for tracheobronchial disorders. Clin Chest Med. 1995;16(3):427–443.
  • Marasso A, Gallo E, Massaglia GM, et al. Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis. Indications, limits, personal experience. Chest. 1993;103(2):472–474.
  • Walsh DA, Maiwand MO, Nath AR, et al. Bronchoscopic cryotherapy for advanced bronchial carcinoma. Thorax. 1990;45(7):509–513.
  • Keller C, Frost A. Fiberoptic bronchoplasty. Description of a simple adjunct technique for the management of bronchial stenosis following lung transplantation. Chest. 1992;102(4):995–998.
  • Hautmann H, Gamarra F, Pfeifer KJ, et al. Fiberoptic bronchoscopic balloon dilatation in malignant tracheobronchial disease: indications and results. Chest. 2001;120(1):43–49.
  • Casal RF. Update in airway stents. Curr Opin Pulm Med. 2010;16(4):321–328.
  • Dumon JF. A dedicated tracheobronchial stent. Chest. 1990;97(2):328–332. • Historically important paper describing the first uses of the silicone Y stent.
  • Dumon MC, Dumon JF, Perrin C, et al. Silicone tracheobronchial endoprosthesis. Rev Mal Respir. 1999;16(4 Pt 2):641–651.
  • Lund ME, Garland R, Ernst A. Airway stenting: applications and practice management considerations. Chest. 2007;131(2):579–587.
  • Bolliger CT, Probst R, Tschopp K, et al. Silicone stents in the management of inoperable tracheobronchial stenoses. Indications and limitations. Chest. 1993;104(6):1653–1659.
  • Bolliger CT, Heitz M, Hauser R, et al. An airway wallstent for the treatment of tracheobronchial malignancies. Thorax. 1996;51(11):1127–1129.
  • Miyazawa T, Yamakido M, Ikeda S, et al. Implantation of ultraflex nitinol stents in malignant tracheobronchial stenoses. Chest. 2000;118(4):959–965.
  • Saad CP, Murthy S, Krizmanich G, et al. Self-expandable metallic airway stents and flexible bronchoscopy: long-term outcomes analysis. Chest. 2003;124(5):1993–1999.
  • Wood DE, Liu YH, Vallieres E, et al. Airway stenting for malignant and benign tracheobronchial stenosis. Ann Thorac Surg. 2003;76(1):167–172; discussion 173–164.
  • Razi SS, Lebovics RS, Schwartz G, et al. Timely airway stenting improves survival in patients with malignant central airway obstruction. Ann Thorac Surg. 2010;90(4):1088–1093.
  • Klopp AH, Eapen GA, Komaki RR. Endobronchial brachytherapy: an effective option for palliation of malignant bronchial obstruction. Clin Lung Cancer. 2006;8(3):203–207.
  • Seaman JC, Musani AI. Endobronchial ablative therapies. Clin Chest Med. 2013;34(3):417–425.
  • Andolino DL, Forquer JA, Henderson MA, et al. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. Int J Radiat Oncol Biol Phys. 2011;80(3):692–697.
  • Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833–4839.
  • Rodrigues G, Videtic GM, Sur R, et al. Palliative thoracic radiotherapy in lung cancer: an American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol. 2011;1(2):60–71. • Important guidelines on the use of radiotherapy in lung cancer.
  • Mallick I, Sharma SC, Behera D, et al. Optimization of dose and fractionation of endobronchial brachytherapy with or without external radiation in the palliative management of non-small cell lung cancer: a prospective randomized study. J Cancer Res Ther. 2006;2(3):119–125.
  • Sur R,Ahemed SN, Donde B, et al. Brachytherapy boost vs teletherapy boost in palliation of symptomatic, locally advanced non-small cell lung cancer: preliminary analysis of a randomized, prospective study. Journal of Brachytherapy International. 2001;17(4):309–315.
  • Langendijk H, de Jong J, Tjwa M, et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol. 2001;58(3):257–268. • An important clinical trial that demonstrates the superiority of EBRT in comparison to EBB.
  • Stout R, Barber P, Burt P, et al. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol. 2000;56(3):323–327.
  • Lester JF, Macbeth FR, Toy E, et al. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev. 2006;4:CD002143. DOI: 10.1002/14651858.CD002143.pub4.
  • Chetty KG, Moran EM, Sassoon CS, et al. Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma. Chest. 1989;95(3):582–584.
  • Mallow C, Thiboutot J, Semaan R, et al. Combination external beam radiation therapy with airway stenting leads to improved survival in patients with malignant central airway obstruction. Respirology. 2018. [Epub ahead of print].
  • Chella A, Ambrogi MC, Ribechini A, et al. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study. Lung Cancer. 2000;27(3):169–175.
  • Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med. 2012;186(6):487–492.
  • Stather DR, Tremblay A. Use of tunneled pleural catheters for outpatient treatment of malignant pleural effusions. Curr Opin Pulm Med. 2007;13(4):328–333.
  • Schulze M, Boehle AS, Kurdow R, et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg. 2001;71(6):1809–1812.
  • Genc O, Petrou M, Ladas G, et al. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg. 2000;18(2):143–146.
  • Clive AO, Jones HE, Bhatnagar R, et al. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2016;5:Cd010529. DOI: 10.1002/14651858.CD010529.pub2.
  • Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest. 1994;106(2):342–346.
  • Campos JR, Werebe EC, Vargas FS, et al. Respiratory failure due to insufflated talc. Lancet. 1997;349(9047):251–252.
  • de Campos JR, Vargas FS, de Campos Werebe E, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001;119(3):801–806.
  • Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. 2007;369(9572):1535–1539. • An important prospective study of over 500 patients which demonstrates the safey of using talc poudrage.
  • Xia H, Wang XJ, Zhou Q, et al. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS One. 2014;9(1):e87060.
  • Parulekar W, Di Primio G, Matzinger F, et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest. 2001;120(1):19–25. •• A pivotal trial demonstrating that clinicans can use small-bore chest tubes, rather than surgical chest tubes, for pleurodesis.
  • Clementsen P, Evald T, Grode G, et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med. 1998;92(3):593–596.
  • Caglayan B, Torun E, Turan D, et al. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann Surg Oncol. 2008;15(9):2594–2599.
  • Antunes G, Neville E, Duffy J, et al. Pleural diseases group SoCCBTS. BTS guidelines for the management of malignant pleural effusions. Thorax. 2003;58(Suppl 2):ii29–38. •• An important and well recognized guidelines for the management of malignant pleural effusions.
  • Putnam JB Jr. Malignant pleural effusions. Surg Clin North Am. 2002;82(4):867–883.
  • Sioris T, Sihvo E, Salo J, et al. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis. Eur J Surg Oncol. 2009;35(5):546–551.
  • Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307(22):2383–2389. • An important clinical trial comparing IPC to pleurodesis for malignant pleural effusions.
  • Thomas R, Fysh ETH, Smith NA, et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial. Jama. 2017;318(19):1903–1912. • An important clinical trial comparing hospitalization days as well as adverse events in patients randomized to IPC or talc pleurodesis.
  • Fysh ET, Waterer GW, Kendall PA, et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012;142(2):394–400.
  • Fysh ET, Tremblay A, Feller-Kopman D, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144(5):1597–1602.
  • Amjadi K, Voduc N, Cruysberghs Y, et al. Impact of interventional bronchoscopy on quality of life in malignant airway obstruction. Respiration; International Review of Thoracic Diseases. 2008;76(4):421–428.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.